Excess deaths in China during SARS-CoV-2 viral waves in 2022-2023

被引:0
|
作者
Jha, Prabhat [1 ,2 ]
Brown, Patrick E. [1 ,2 ]
Lam, Teresa [3 ]
Morawski, Ed [3 ]
Reid, Angus [3 ]
机构
[1] Unity Hlth Toronto, Ctr Global Hlth Res, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Angus Reid Inst, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/j.pmedr.2024.102687
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The extent to which the Omicron variant of SARS-CoV-2 raised death rates in China during its viral wave of December 2022 -January 2023 remains largely undocumented. Methods: We worked with an established national survey organization to survey 8,004 adults in all 31 administrative areas of China to ask about deaths in families since January 2020. We examined age -specific death rates, focusing on deaths above age 60 years, and at 15 -59 years. We compared these to the United Nations (UN) estimates of age -specific mortality in 2019. Findings: The survey participants were broadly similar to the 2020 census and other national surveys in age, sex, region, and smoking status, but had lower SARS-CoV2 vaccination rates and higher education levels. There were no differences in reporting of deaths during the Omicron period (after November 2021) versus earlier. The survey captured 456 deaths, of which 329 occurred at ages 60 + years and 212 were of women. At ages 60 + years, death rates approximately doubled during December 2022 -January 2023. Deaths at ages 15 -59 years did not rise appreciably. The UN estimates approximately 675,000 deaths per month at ages 60 + years in 2019. If rates doubled nationally as in our survey, China had approximately 1.35 million excess deaths from December 2022 -January 2023. Interpretation: China experienced a sharp but short increase in excess deaths among its elderly during the Omicron wave. If death registry data corroborate our estimates of substantial excess deaths in China, the worldwide estimates of excess deaths due to SARS-CoV-2 in 2022 -2023 may need upward adjustment.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Circulation and Codetections of Influenza Virus, SARS-CoV-2, Respiratory Syncytial Virus, Rhinovirus, Adenovirus, Bocavirus, and Other Respiratory Viruses During 2022-2023 Season in Latvia
    Kampenusa, Inara
    Niedre-Otomere, Baiba
    Trofimova, Julija
    Pole, Ilva
    Pakarna, Gatis
    Savicka, Oksana
    Nikisins, Sergejs
    VIRUSES-BASEL, 2024, 16 (11):
  • [22] Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection
    Sharif-Askari, Narjes Saheb
    Sharif-Askari, Fatemeh Saheb
    Ahmed, Samrein B. M.
    Hannawi, Suad
    Hamoudi, Rifat
    Hamid, Qutayba
    Halwani, Rabih
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] Deaths after detected SARS-CoV-2 in Norway
    Gulseth, Hanne Lovdal
    Helland, Eyvind
    Johansen, Knut Ivar
    Gravningen, Kirsten
    Eide, Helena Niemi
    Haberg, Siri Eldevik
    Bakken, Inger Johanne
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (18) : 1874 - 1878
  • [24] SARS-CoV-2 viral sepsis with meningoencephalitis
    Dharsandiya, Mitkumar
    Shah, Kinjal
    Patel, Ketan
    Patel, Tushar
    Patel, Amrish
    Patel, Atul
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2020, 38 (02) : 219 - 221
  • [25] SARS-CoV-2 Mutations and their Viral Variants
    Cosar, Begum
    Karagulleoglu, Zeynep Yagmur
    Unal, Sinan
    Ince, Ahmet Turan
    Uncuoglu, Dilruba Beyza
    Tuncer, Gizem
    Kilinc, Bugrahan Regaip
    Ozkan, Yunus Emre
    Ozkoc, Hikmet Ceyda
    Demir, Ibrahim Naki
    Eker, Ali
    Karagoz, Feyzanur
    Simsek, Said Yasin
    Yasar, Bunyamin
    Pala, Mehmetcan
    Demir, Aysegul
    Atak, Irem Naz
    Mendi, Aysegul Hanife
    Bengi, Vehdi Umut
    Sevel, Guldane Cengiz
    Altuntas, Evrim Gunes
    Kilic, Pelin
    Demir-Dora, Devrim
    CYTOKINE & GROWTH FACTOR REVIEWS, 2022, 63 : 10 - 22
  • [26] Surveillance of SARS-CoV-2 variants in Henan, China from 2023 to 2024
    Song, Yun
    Wu, Bicong
    Ma, Hongxia
    Li, Yafei
    Yan, Su
    Pan, Jingjing
    Wang, Haifeng
    Ye, Ying
    Huang, Xueyong
    Guo, Wanshen
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2025, 15
  • [27] SARS-CoV-2 Surveillance Through China Influenza Surveillance Information System - China, December 1, 2022 to February 12, 2023
    Zeng, Xiaoxu
    Xie, Yiran
    Yang, Xiaokun
    Peng, Zhibin
    Tang, Jing
    Yang, Lei
    Lin, Shuxia
    Han, Jun
    Zhang, Yanping
    Wang, Dayan
    CHINA CDC WEEKLY, 2023, 5 (07): : 152 - 158
  • [28] SARS-CoV-2 Infection and Sequelae in Febrile Patients in Six Hospitals along the Thai-Lao and Thai-Myanmar Borders, 2022-2023
    Bhengsri, Saithip
    Bloss, Emily
    Sawatwong, Pongpun
    Chuenchom, Nuttagarn
    Lertwitayakumjorn, Tanaphat
    Piralam, Barameht
    Chaoprasert, Samkan
    Simmali, Tuwan
    Bungkanjana, Pornpan
    Heffelfinger, James
    Sujariyakul, Anupong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [29] SARS-CoV-2 viral RNA levels are not 'viral load'
    Michalakis, Yannis
    Sofonea, Mircea T.
    Alizon, Samuel
    Bravo, Ignacio G.
    TRENDS IN MICROBIOLOGY, 2021, 29 (11) : 970 - 972
  • [30] SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
    Cohn, Barbara A.
    Cirillo, Piera M.
    Murphy, Caitlin C.
    Krigbaum, Nickilou Y.
    Wallace, Arthur W.
    SCIENCE, 2022, 375 (6578) : 331 - +